Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,000
Closed -$60K 1000
2020
Q4
$60K Buy
+1,000
New +$61.5K ﹤0.01% 950

Other funds holding BMY

Vontobel Holding's BMY Position: Q2 2026 in Review

Vontobel Holding increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, buying an estimated $1.71M and bringing the position to 725,587 shares worth $41.8M. The position accounts for 0.13% of the portfolio, ranked #154.

Vontobel Holding first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $132M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vontobel Holding held 725,587 shares of Bristol-Myers Squibb worth $41.8M as of Q2 2026.
  • Vontobel Holding bought 29,767 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.71M.
  • Bristol-Myers Squibb made up 0.13% of Vontobel Holding's portfolio in Q2 2026, its #154 holding.
  • Vontobel Holding first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Bristol-Myers Squibb position peaked at $132M in Q4 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.